Skip to content
NEJM Interviews cover art

All Episodes

NEJM Interviews — 958 episodes · page 3 of 10

#
Title
201

NEJM Interview: Kimani Paul-Emile on U.S. laws aimed at protecting against discrimination in health care contexts and why such discrimination endures.

202

NEJM Interview: Ari Ne’eman on opportunities to support access to home- and community-based services for people with disabilities.

203

Ending the Covid-19 Emergency

204

NEJM Interview: Claire Ankuda on ensuring access to high-quality and equitable care in Medicare Advantage.

205

NEJM Interview: Carolyn Gould on overcoming challenges related to developing vaccines for preventing West Nile virus disease.

206

Preparing for the Next Pandemic

207

NEJM Interview: Prof. Arti Rai on U.S. legal regimes governing access to biomedical innovation.

208

NEJM Interview: Profs. Michelle Mello and Guy Palmer on wastewater surveillance during the Covid-19 pandemic and beyond.

209

When to Get a Second Covid-19 Booster Shot

210

NEJM Interview: Prof. Elizabeth Tobin-Tyler on recent court decisions related to gun possession by people subject to certain types of restraining orders.

211

NEJM Interview: Dr. Joseph Ross on shifts in the FDA’s use of accelerated approval and associated challenges for clinicians and patients.

212

Ending the Covid-19 Public Health Emergency

213

NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.

214

NEJM Interview: Prof. Jaime King on the functions of antitrust law and the effects of health care consolidation on prices, quality of care, and access to care.

215

The Future of Covid-19 Research

216

NEJM Interview: Dr. Ashley Leech on the potential implications of Medicare Part D covering medications for obesity treatment.

217

NEJM Interview: Dr. Winfred W. Williams on strategies for recruiting and supporting medical students, trainees, and faculty from diverse backgrounds.

218

The Fauci Phenomenon

219

The Path Forward for Covid-19 Therapeutics

220

NEJM Interview: Jeremiah Johnson on a proposed program to increase uptake of HIV preexposure prophylaxis and address disparities in access.

221

NEJM Interview: Prof. Zack Buck on U.S. laws governing health care fraud and abuse and financial conflicts of interest.

222

What to Expect from Covid-19 Vaccines

223

NEJM Interview: Dr. Konstantin Chumakov on current polio-immunization strategies and future directions for eradication efforts.

224

NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

225

Updating and Standardizing Covid-19 Vaccines

226

NEJM Interview: Dr. Wafaa El-Sadr on navigating the current moment in the Covid-19 pandemic and learning lessons from past successes and missteps.

227

NEJM Interview: Prof. Kimberly Mutcherson on the Dobbs v. Jackson Women’s Health Organization decision and states’ power to determine when life begins.

228

Weighing the Protective Value of Covid-19 Infection

229

NEJM Interview: Dr. Julianne Holt-Lunstad on the association between social connection and health.

230

Covid-19 Vaccines and New Viral Variants

231

NEJM Interview: Dr. David Ansell and Redia Holman on an approach for health care institutions to build community health and wealth.

232

The Expanding Arsenal of Oral Agents to Treat Covid-19

233

NEJM Interview: Prof. Michelle Mello on Braidwood Management Inc. v. Becerra and its potential implications.

234

NEJM Interview: Dr. Armand Sprecher on the importance of mutual understanding in outbreak control, focusing on a recent outbreak of Sudan virus disease.

235

Potential Covid Vaccine Strategies

236

NEJM Interview: Prof. Sabrina Corlette on the history of the U.S. health insurance system and persistent coverage and affordability challenges.

237

Applying New Studies of Mpox and Ebola to Covid-19

238

NEJM Interview: Dr. David Blumenthal on a new federal rule that requires health care providers and other entities to share patient information.

239

Covid-19 and Health Equity

240

NEJM Interview: Robert Shireman on policy changes allowing accreditation of for-profit medical schools in the United States

241

Five Disease Outbreaks beyond Covid-19

242

NEJM Interview: Dr. Anthony Fauci on the evolution of the field of infectious diseases during his tenure at the National Institute of Allergy and Infectious Diseases.

243

Making Choices about Covid-19

244

NEJM Interview: Prof. Sharona Hoffman on laws protecting patients’ health information.

245

The FDA and Covid-19 Vaccines

246

NEJM Interview: Dr. Ateev Mehrotra on federal pandemic-era telemedicine policies and research that could help inform permanent regulations.

247

Masking and Covid-19

248

NEJM Interview: Dr. Mark Pallansch on an outbreak of imported poliovirus in the United States.

249

Caring for Hospitalized Patients with Covid-19

250

NEJM Interview: Dr. Srijan Sen on the current emphasis on distinguishing burnout from depression and possible unintended consequences for physician well-being.

251

Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection

252

NEJM Interview: Dr. David Studdert on the U.S. malpractice system and its effects on medical decision making.

253

Covid-19: Where Are We Heading?

254

NEJM Interview: Dr. Stacie Dusetzina on the potential effects of new legislation on spending on prescription drugs.

255

Developing New Covid-19 Vaccines

256

NEJM Interview: Dr. Rahul Gupta on strategies for promoting use of medication for opioid use disorder.

257

Infectious Disease in Africa

258

NEJM Interview: Prof. Michael Ulrich on the Supreme Court’s decision in New York State Rifle & Pistol Association v. Bruen and its implications for public health.

259

Assessing Bivalent Vaccines against Covid-19

260

NEJM Interview: Dr. James Garbarino on the effects of exposure to gun violence on child and adolescent development.

261

Can Vaccines Prevent Transmission of Covid-19?

262

NEJM Interview: Prof. Nathan Cortez on legal and regulatory systems designed to prevent avoidable medical errors in the United States.

263

Developing Mucosal Immunity to Covid-19

264

NEJM Interview: Dr. Sonja Rasmussen on protecting pregnant people and babies from climate-change–related harm.

265

Rolling Out New Covid-19 Vaccines

266

NEJM Interview: Prof. Sara Rosenbaum on the conflict between EMTALA and restrictive state abortion laws.

267

Covid-19 and the WHO

268

NEJM Interview: Dr. Eric Perakslis on cybersecurity threats to patients and health care systems.

269

Choosing an Antiviral to Treat Covid-19

270

NEJM Interview: Dr. Arthur Derse on the duties that physicians owe their patients and challenges to the physician–patient relationship.

271

Responding to Monkeypox

272

NEJM Interview: Dr. Vivek Murthy on approaches to supporting well-being among health workers.

273

Combating Covid-19 Today and Tomorrow

274

NEJM Interview: Prof. Timothy Jost on litigation challenging the consideration of race and ethnicity in the allocation of scarce Covid-19 treatments.

275

Updated Covid-19 Vaccines and a Look at Monkeypox

276

Reinventing the Research Infrastructure to Address Covid-19

277

NEJM Interview: Prof. Erin Fuse Brown on the history of health law in the United States and potential future directions for the field.

278

A Look at the U.S. Government’s Covid-19 Strategy

279

NEJM Interview: Dr. Vinay Rathi on the medical device user-fee program and strategies for supporting device safety and innovation.

280

Covid-19 Vaccines and the FDA

281

NEJM Interview: Dr. Rishi Wadhera on the inequitable effects of value-based payment programs and a new model meant to respond to equity concerns.

282

Designing the Next Covid-19 Vaccine

283

NEJM Interview: Dr. Richard Baron on the role of certifying boards in addressing the problem of false information on social media.

284

How Effective is Covid-19 Vaccination in Children?

285

NEJM Interview: Dr. Ankur Pandya on rigorously assessing the costs and benefits of various policy options for combating Covid-19.

286

Vaccinating Young Children against Covid-19

287

NEJM Interview: Dr. Ismail Jatoi on factors that have contributed to higher breast-cancer mortality among Black women than White women in the United States.

288

NEJM Interview: Dr. Lauren Thaxton on the adverse effects on patients, physicians, and trainees of the new Texas abortion law.

289

Viral Evolution and the Future of Monoclonal Antibodies

290

NEJM Interview: Prof. Lisa Heinzerling on West Virginia v. EPA and how the Supreme Court evaluates environmental and public health actions by federal agencies.

291

Protecting the Immunocompromised from Covid-19

292

NEJM Interview: Dr. Leemore Dafny on a new approach for bringing down insulin prices in the United States.

293

Dissecting the Host Response to SARS-CoV-2

294

Waning Immunity against Covid-19

295

NEJM Interview: Dr. Elizabeth Samuels on overdose-prevention centers and federal policy.

296

NEJM Interview: Dr. Richard Pierson on the implications of recent efforts to transplant pig organs into humans.

297

Audio of Perspective Roundtable on Long-Term Care in the United States

298

Forecasting the Future of Covid

299

NEJM Interview: Dr. Jonathan Oberlander on health care successes and struggles under the Biden administration.

300

NEJM Interview: Dr. Lisa Harris on preparing for the effects on patients and trainees of the likely overturning of Roe v. Wade.